Loading clinical trials...
Loading clinical trials...
Low Dose Danazol for the Treatment of Telomere Related Diseases
Conditions
Interventions
Danazol
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
February 8, 2018
Primary Completion Date
April 29, 2026
Completion Date
October 29, 2027
Last Updated
December 17, 2025
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions